Rules concerning license and screening of biological preparations, etc. revised
Published: 2003-05-26 06:59:00
Updated: 2003-05-26 06:59:00
The Korea Food and Drug Administration announced on May 23 that it revised rules concerning license and screening of biological preparations and biotechnology based drugs so as to separate these items from OTC products defined in the same category.
The KFDA explained that under the newly revis...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
